106 related articles for article (PubMed ID: 22863696)
1. Factors affecting the bitterness intensities of ten commercial formulations of ambroxol.
Uchida T; Sugino Y; Hazekawa M; Yoshida M; Haraguchi T
Chem Pharm Bull (Tokyo); 2012; 60(8):949-54. PubMed ID: 22863696
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of palatability of 10 commercial amlodipine orally disintegrating tablets by gustatory sensation testing, OD-mate as a new disintegration apparatus and the artificial taste sensor.
Uchida T; Yoshida M; Hazekawa M; Haraguchi T; Furuno H; Teraoka M; Ikezaki H
J Pharm Pharmacol; 2013 Sep; 65(9):1312-20. PubMed ID: 23927469
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the palatabilities in 10 different famotidine orally disintegrating tablets by combination of disintegration device and taste sensor.
Yoshida M; Hazekawa M; Haraguchi T; Uchida T
Drug Dev Ind Pharm; 2015; 41(8):1387-92. PubMed ID: 25196898
[TBL] [Abstract][Full Text] [Related]
4. [Comprehensive evaluation of palatability for commercial medicine by taste sensing system].
Uchida T
Yakugaku Zasshi; 2014; 134(3):317-23. PubMed ID: 24584008
[TBL] [Abstract][Full Text] [Related]
5. Famotidine orally disintegrating tablets: bitterness comparison of original and generic products.
Tokuyama E; Matsunaga C; Yoshida K; Mifsud JC; Irie T; Yoshida M; Uchida T
Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):382-7. PubMed ID: 19336932
[TBL] [Abstract][Full Text] [Related]
6. Bitterness-Masking Effects of Different Beverages on Zopiclone and Eszopiclone Tablets.
Yoshida M; Kojima H; Uda A; Haraguchi T; Ozeki M; Kawasaki I; Yamamoto K; Yano I; Hirai M; Uchida T
Chem Pharm Bull (Tokyo); 2019; 67(5):404-409. PubMed ID: 31061364
[TBL] [Abstract][Full Text] [Related]
7. Bitterness evaluation of acidic pharmaceutical substances (NSAIDs) using a taste sensor.
Yoshida M; Haraguchi T; Uchida T
Chem Pharm Bull (Tokyo); 2014; 62(12):1252-8. PubMed ID: 25450633
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a reversed-phase HPLC method for simultaneous estimation of ambroxol hydrochloride and azithromycin in tablet dosage form.
Shaikh KA; Patil SD; Devkhile AB
J Pharm Biomed Anal; 2008 Dec; 48(5):1481-4. PubMed ID: 18993009
[TBL] [Abstract][Full Text] [Related]
9. Bitterness evaluation of medicines for pediatric use by a taste sensor.
Ishizaka T; Miyanaga Y; Mukai J; Asaka K; Nakai Y; Tsuji E; Uchida T
Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):943-8. PubMed ID: 15304986
[TBL] [Abstract][Full Text] [Related]
10. Oral sustained delivery of ambroxol from in situ-gelling pectin formulations.
Kubo W; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
Int J Pharm; 2004 Mar; 271(1-2):233-40. PubMed ID: 15129990
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
[TBL] [Abstract][Full Text] [Related]
12. Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulations.
Kardos P; Beeh KM; Sent U; Mueck T; Gräter H; Michel MC
BMC Pharmacol Toxicol; 2018 Jul; 19(1):40. PubMed ID: 29973292
[TBL] [Abstract][Full Text] [Related]
13. Citric Acid Suppresses the Bitter Taste of Olopatadine Hydrochloride Orally Disintegrating Tablets.
Sotoyama M; Uchida S; Tanaka S; Hakamata A; Odagiri K; Inui N; Watanabe H; Namiki N
Biol Pharm Bull; 2017; 40(4):451-457. PubMed ID: 28381800
[TBL] [Abstract][Full Text] [Related]
14. An oral controlled release system for ambroxol hydrochloride containing a wax and a water insoluble polymer.
Chi N; Guo JH; Zhang Y; Zhang W; Tang X
Pharm Dev Technol; 2010; 15(1):97-104. PubMed ID: 19671037
[TBL] [Abstract][Full Text] [Related]
15. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
Kibria G; Islam KM; Jalil RU
Pak J Pharm Sci; 2009 Jan; 22(1):36-43. PubMed ID: 19168418
[TBL] [Abstract][Full Text] [Related]
16. Quantitative prediction of the bitterness suppression of elemental diets by various flavors using a taste sensor.
Miyanaga Y; Inoue N; Ohnishi A; Fujisawa E; Yamaguchi M; Uchida T
Pharm Res; 2003 Dec; 20(12):1932-8. PubMed ID: 14725356
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
[TBL] [Abstract][Full Text] [Related]
18. A new method for evaluating the bitterness of medicines in development using a taste sensor and a disintegration testing apparatus.
Harada T; Uchida T; Yoshida M; Kobayashi Y; Narazaki R; Ohwaki T
Chem Pharm Bull (Tokyo); 2010 Aug; 58(8):1009-14. PubMed ID: 20686251
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of bitterness suppression of macrolide dry syrups by jellies.
Tsuji E; Uchida T; Fukui A; Fujii R; Sunada H
Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):310-4. PubMed ID: 16508183
[TBL] [Abstract][Full Text] [Related]
20. The quantitative prediction of bitterness-suppressing effect of sweeteners on the bitterness of famotidine by sweetness-responsive sensor.
Hashimoto Y; Matsunaga C; Tokuyama E; Tsuji E; Uchida T; Okada H
Chem Pharm Bull (Tokyo); 2007 May; 55(5):739-46. PubMed ID: 17473460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
